Viking Therapeutics, Inc. (VKTX) has a consensus analyst rating of Buy, based on 23 analysts covering the stock. Of those, 22 recommend buying, 1 recommend holding, and 0 recommend selling.
The analyst consensus price target for VKTX is $103.00, representing a +190.0% upside from the current price of $35.52. Price targets range from a low of $99.00 to a high of $107.00.
